4//SEC Filing
Taveras Arthur 4
Accession 0001628280-22-002507
CIK 0001501697other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:21 PM ET
Size
5.2 KB
Accession
0001628280-22-002507
Insider Transaction Report
Form 4
Taveras Arthur
Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2022-02-11−928→ 7,107 total
Footnotes (3)
- [F1]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]Shares withheld by X4 Pharmaceuticals Inc. to satisfy taxes payable in connection with the vesting of previously awarded restricted stock units.
- [F3]Of the shares of common stock reported, 5,357 shares represent unvested restricted stock units.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001830901
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:21 PM ET
- Size
- 5.2 KB